Selective blockade of serotonin 5-HT2A receptor increases coronary blood flow via augmented cardiac nitric oxide release through 5-HT1B receptor in hypoperfused canine hearts

Journal of Molecular and Cellular Cardiology

Volumn 37, Issue 6, 2004, Pages 1219-1223

  Fujita, Masashi ^a   Minamino, Tetsuo ^a   Sanada, Shoji ^a   Asanuma, Hiroshi ^a   Hirata, Akio ^a   Ogita, Hisakazu ^a   Okada, Ken Ichiro ^a   Tsukamoto, Osamu ^a   Takashima, Seiji ^a   Tomoike, Hitonobu ^b   Node, Koichi ^c   Hori, Masatsugu ^a   Kitakaze, Masafumi ^b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c SAGA UNIVERSITY   (Japan)

Author keywords

5HT); Coronary circulation; Ischemia; Nitric oxide (NO); Sarpogrelate; Serotonin (5 hydroxytryptamine

Indexed keywords

3 (3 DIMETHYLAMINOPROPYL) 4 HYDROXY N [4 (4 PYRIDINYL)PHENYL]BENZAMIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; SARPOGRELATE; SEROTONIN 1B ANTAGONIST; SEROTONIN 1B RECEPTOR; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY DILATATION; DOG; DRUG EFFECT; ENZYME ACTIVATION; HEART MUSCLE ISCHEMIA; HEART PERFUSION; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; SEROTONIN RELEASE;

ANIMALS; DOGS; HEART; IMMUNOHISTOCHEMISTRY; MYOCARDIUM; NITRIC OXIDE; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN; SUCCINATES; TIME FACTORS;

CANIS FAMILIARIS;

EID: 9644263892     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2004.09.016     Document Type: Article

References (20)

1. P. Golino, F. Piscione, J.T. Willerson, M. Cappelli-Bigazzi, A. Focaccio, and B. Villari Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients N. Engl. J. Med. 324 1991 641 648
2. P.M. Vanhoutte Endothelial dysfunction and vascular disease Verh. K. Acad. Geneeskd. Belg. 60 1998 251 266
3. A. Banes, J.A. Florian, and S.W. Watts Mechanisms of 5- hydroxytryptamine(2A) receptor activation of the mitogen-activated protein kinase pathway in vascular smooth muscle J. Pharmacol. Exp. Ther. 291 1999 1179 1187
4. K. Nakamura, H. Kariyazono, H. Masuda, R. Sakata, and K. Yamada Effects of sarpogrelate hydrochloride on adenosine diphosphate- or collagen-induced platelet responses in arteriosclerosis obliterans Blood Coagul. Fibrin. 12 2001 391 397
5. M. Kitakaze, T. Minamino, K. Node, K. Komamura, Y. Shinozaki, and H. Mori Beneficial effects of inhibition of angiotensin-converting enzyme on ischemic myocardium during coronary hypoperfusion in dogs Circulation 92 1995 950 961
6. T. Kandabashi, H. Shimokawa, Y. Mukai, T. Matoba, I. Kunihiro, and K. Morikawa Involvement of rho-kinase in agonists-induced contractions of arteriosclerotic human arteries Arterioscler Thromb. Vasc. Biol. 22 2002 243 248
7. J. Hansen-Schwartz, N. Lovland Hoel, E. Nilsson, P. Tfelt-Hansen, and L. Edvinsson Endothelium-dependent relaxant responses to selective 5-HT(1B/1D) receptor agonists in the isolated middle cerebral artery of the rat J. Vasc. Res. 40 2003 561 566
8. L.C. Green, D.A. Wagner, J. Glogowski, J.S. Skipper, and S.R. Wishnok Analysis of nitrate, nitrite and [15N]nitrate in biological fluids Anal. Biochem. 126 1982 131 138
9. J. Ishida, R. Iizuka, and M. Yamaguchi High-performance liquid chromatographic determination of 5-hydroxyindoles by post-column fluoresecence derivatization Analyst 118 1993 165 169
10. T. Minamino, M. Kitakaze, P.J. Papst, Y. Ueda, Y. Sakata, and H. Asanuma Inhibition of nitric oxide synthesis induces coronary vascular remodeling and cardiac hypertrophy associated with the activation of p70 S6 kinase in rats Cardiovasc. Drugs Ther. 14 2000 533 542
11. T. Ishida, S. Kawashima, K. Hirata, and M. Yokoyama Nitric oxide is produced via 5-HT1B and 5-HT2B receptor activation in human coronary artery endothelial cells Kobe J. Med. Sci. 44 1998 51 63
12. S. Moncada, R.M. Palmer, and E.A. Higgs Nitric oxide: physiology, pathophysiology, and pharmacology Pharmacol. Rev. 43 1991 109 142
13. J.C. Shih, K. Chen, and M.J. Ridd Monoamine oxidase: from genes to behavior Annu. Rev. Neurosci. 22 1999 197 217
14. O.R. Kunduzova, P. Bianchi, A. Parini, and C. Cambon Hydrogen peroxide production by monoamine oxidase during ischemia/reperfusion Eur. J. Pharmacol. 448 2002 225 230
15. S. Takano, Y. Hoshino, L. Li, I. Matsuoka, T. Ono, and J. Kimura Dual roles of 5-hydroxytryptamine in ischemia-reperfusion injury in isolated rat hearts J. Cardiovasc. Pharmacol. Ther. 9 2004 43 50
16. V. Parikh, and M. Singh Resident cardiac mast cells and the cardioprotective effect of ischemic preconditioning in isolated rat heart J. Cardiovasc. Pharmacol. 30 1997 149 156
17. S. Singh, P.I. Johnson, A. Javed, T.S. Gray, V.A. Lonchyna, and R.D. Wurster Monoamine- and histamine-synthesizing enzymes and neurotransmitters within neurons of adult human cardiac ganglia Circulation 99 1999 411 419
18. Y. Shimizu, S. Minatoguchi, K. Hashimoto, Y. Uno, M. Arai, and N. Wang The role of serotonin in ischemic cellular damage and the infarct size-reducing effect of sarpogrelate, a 5-hydroxytryptamine-2 receptor blocker, in rabbit hearts J. Am. Coll. Cardiol. 40 2002 1347 1355
19. T. Tanaka, M. Fujita, I. Nakae, S. Tamaki, K. Hasegawa, and Y. Kihara Improvement of exercise capacity by sarpogrelate as a result of augmented collateral circulation in patients with effort angina J. Am. Coll. Cardiol. 32 1998 1982 1986
20. M. Kitakaze, K. Node, T. Minamino, H. Asanuma, T. Kuzuya, and M. Hori A Ca channel blocker, benidipine, increases coronary blood flow and attenuates the severity of myocardial ischemia via NO-dependent mechanisms in dogs J. Am. Coll. Cardiol. 33 1999 242 249